Hannover Re (HVRRY) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Hannover Re $38.84, price $48.04, upside -19.2%, quality 58 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Hannover Re for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $19.19 – $51.76 · fair‑value band $29.89 – $69.71 · the $48.04 price screens above the $38.84 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Hannover Re in your weekly email
Every Wednesday you see whether Hannover Re is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services in Germany, the United Kingdom, France, Europe, the United States, Asia, Australia, Africa, and internationally. It operates through Property & Casualty Reinsurance; and Life & Health Reinsurance segments.
Show more
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services in Germany, the United Kingdom, France, Europe, the United States, Asia, Australia, Africa, and internationally. It operates through Property & Casualty Reinsurance; and Life & Health Reinsurance segments. The company provides property and casualty reinsurance solutions for agricultural, livestock, and bloodstock; aviation and space; natural catastrophe; credit, surety, and political risks; cyber; digital; marine and upstream energy; natural catastrophes; advanced and facultative business, insurance-linked securities and structured reinsurance; and parametric solutions. It also offers risk solutions in the areas of critical illness, disability, health, longevity, long term care, and mortality. In addition, the company offers group life, retirement, lifestyle, credit life, and Takaful reinsurance products. Further, the company provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and reinsurance and solvency II businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. Hannover Rück SE was founded in 1966 and is based in Hanover, Germany. Hannover Rück SE operates as a subsidiary of Talanx AG.
Stock analysis
Hannover Re (HVRRY) currently trades at $48.04, while our model-based Fair Value estimate is $38.84, implying the stock looks roughly 23.7% overvalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of $31.32 per share, and 0 of the 6 models we run sit above the $48.04 price.
Bear case: the Asset-Based group reads lowest at $11.97, and 6 of the 6 models stay below the price. Evidence for this calculation is high.
Scenario range: $29.89 (bear) to $69.71 (bull), the price of $48.04 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 58/100 (solid quality), in the Financial Services sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Hannover Re reported revenue of €24.0B in FY2025 versus €26.1B in FY2021, a compound −2.1%/yr. Reported net income was €2.6B in FY2025, compounding +21.0%/yr from FY2021.
Key figures
Market cap $34.8B · P/E ratio 10.4 · P/S ratio 1.15 · EPS (TTM) $4.61 · Dividend yield 5.5% · Net margin 11.0% · Return on equity 21.7% · Return on assets (EBIT) 3.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 54 out of 100 (medium confidence).
What moves the price
The share trades about 7% below its 52-week high and 11% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at 24% fair-value upside, at −19%, HVRRY screens richer than that median.
Fair Value models
Bear $29.89Fair Value $38.84Bull $69.71
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+804.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+158.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.6%
Start year 2020 (pandemic). Over 10 years: +3.9% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+22.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+16.5%
Dividend (yield on the price)5.5%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.17% vs 9%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 14%
Start year 2020 (pandemic)
⚠ Revenue per share shrinking 15.3%/yr over ~10Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−15.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+5.6%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in EUR, euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about −17.6% a year for the price and +3.4% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (72 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Neutral
Recent news coverage is roughly neutral, about typical for how stocks are covered.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance - Reinsurance · 28 stocks
Beats the industry median on 4/15 measures
Overall it trails its industry peers.
Valuation
Quality Score52 · Below median
Fair Value upside−19% · Below median
Profitability
Return on equity (TTM)22% · Top 25%
Return on assets4% · Top 25%
Net margin (TTM)12% · Above median
Operating margin (TTM)10% · Bottom 25%
Growth and dividend
Revenue growth−23% · Bottom 25%
Dividend yield (TTM)5.5% · Above median
Balance sheet
Debt / equity0.31× · Above median
Valuation Multiplesvs Insurance - Reinsurance median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Hannover Re Fair Value". https://www.fairvalue-calculator.com/stock/HVRRY
Frequently asked questions
Is Hannover Re (HVRRY) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $38.84 versus a price of $48.04, about −19% upside (overvalued).
What is the fair value of HVRRY?
Our model-based fair value for Hannover Re is $38.84 (as of Sep 24, 2026), built from audited fundamentals. The current price: $48.04.
What is the quality score of HVRRY?
Hannover Re has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Hannover Re (HVRRY)?
Our model-based price target is the fair value of $38.84 (as of Sep 24, 2026) from 6 valuation models. Cautious scenario $29.89, optimistic scenario $69.71. It is a calculation from audited fundamentals, not an analyst target.
What is the Hannover Re stock forecast for 2026?
Our models put fair value at $38.84, about −19% upside versus a price of $48.04 (overvalued). Cautious scenario $29.89, optimistic scenario $69.71. The calculation is refreshed regularly with new filings.
What is the revenue of Hannover Re (HVRRY)?
Hannover Re reported trailing-twelve-month revenue of about €24.3B (latest available figure, as of Sep 24, 2026).
Does Hannover Re pay a dividend?
Hannover Re currently shows a dividend yield of about 5.53% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Hannover Re (HVRRY)?
For today's price to be fair in a discounted-cash-flow model, Hannover Re would have to grow free cash flow by -15.8 % per year for five years (discount rate 8.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +0.6 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of HVRRY use?
Our models discount Hannover Re at 8.1 %: a base by market capitalisation (large), damped by beta 0.13, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Hannover Re that is -15.8 % per year a year over ten years, using the same discount rate (8.1 %) and the same formula as our fair value.
How much growth has Hannover Re (HVRRY) delivered so far?
Over the past 5 years revenue at Hannover Re grew +0.6 % a year. The price currently implies -15.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Hannover Re (HVRRY) growing?
The median revenue growth in the sector is +8.4 % a year. That is the yardstick for the growth priced into Hannover Re (-15.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Hannover Re (HVRRY)?
The free-cash-flow yield on the price is 18.62 %: that much free cash flow Hannover Re produces per unit of market value. When it exceeds the discount rate of our models (8.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Hannover Re (HVRRY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Hannover Re it is $38.84 per share (as of Sep 24, 2026), against a price of $48.04. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is Hannover Re stock overvalued or undervalued in 2026?
As of Sep 24, 2026, HVRRY trades above its calculated fair value: price $48.04, fair value $38.84, a gap of about −19% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HVRRY?
No. The price is what the market pays today ($48.04); the fair value is what the company's own numbers justify ($38.84). For Hannover Re the two are $9.20 per share apart. That gap is exactly why we show both numbers side by side.
How much is Hannover Re worth?
The market values Hannover Re at about $34.8B (market capitalisation, as of Sep 24, 2026). Per share that is $48.04; our models calculate a fair value of $38.84 per share.
What do the bullish and bearish scenarios say about HVRRY?
Our models span a range for Hannover Re: cautious scenario $29.89, base $38.84, optimistic $69.71 per share (as of Sep 24, 2026, price $48.04). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of HVRRY?
Hannover Re trades at a price-to-earnings ratio of 10.4 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $38.84 is built from several models across several years. Other multiples: PEG 2.2, P/B 2.7, P/S 1.4, EV/EBITDA 7.7.
What is the PEG ratio of HVRRY?
The PEG ratio of Hannover Re is 2.18 (P/E divided by earnings growth, as of Sep 24, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Hannover Re (HVRRY)?
Balance-sheet figures for Hannover Re (as of Sep 24, 2026): return on equity 21.7%, debt of 0.31 per unit of equity. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is HVRRY from its 52-week high?
Hannover Re trades at $48.04, about 7% below its 52-week high of $51.76 and 11% above the low of $43.29 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $38.84 is for.
Which stocks are comparable to Hannover Re?
From the same area (Financial Services) we also value MUV2, Swiss Re AG, Hannover Rück SE, Reinsurance Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Hannover Re stock attractive at the current price?
The data as of Sep 24, 2026: price $48.04, calculated fair value $38.84 (−19%), Quality Score 58/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of HVRRY calculated?
We run Hannover Re through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $38.84, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Hannover Re itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Hannover Re (HVRRY)?
The closing price on Sep 23, 2026 was $48.04. Our model-based fair value is $38.84, about −19% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Hannover Re right now?
Solid but not exceptional quality (58/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($29.89 to $69.71) leaves room in how you read the outcome. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of Hannover Re (HVRRY) come from?
Earnings per share at Hannover Re grew +8.3 % a year from 2014 to 2025. Broken into its drivers: revenue per share −5.5 %, EBIT margin +13.2 %, tax rate +1.1 %, residual (interest, one-offs) +0.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Hannover Re
How large is the market capitalisation of Hannover Re (HVRRY)?
The market capitalisation of Hannover Re is $34.8B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Hannover Re (HVRRY)?
The price-to-sales ratio of Hannover Re is 1.15 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Hannover Re (HVRRY)?
Earnings per share at Hannover Re are $4.61 (price ÷ EPS = P/E 10.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Hannover Re (HVRRY)?
The dividend yield of Hannover Re is 5.5% (payout 57.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Hannover Re (HVRRY)?
The net margin of Hannover Re is 11.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Hannover Re (HVRRY)?
The return on equity (ROE) of Hannover Re is 21.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Hannover Re (HVRRY)?
On an EBIT basis the return on assets of Hannover Re is 3.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Hannover Re (HVRRY)?
The operating margin of Hannover Re is 9.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Hannover Re (HVRRY)?
Revenue at Hannover Re is growing −22.8% versus a year earlier (3y avg +159%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Hannover Re (HVRRY)?
Earnings per share at Hannover Re are growing +48.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Hannover Re (HVRRY) carry?
The net debt of Hannover Re is €3.1B (fiscal year 2025, ≈ 0.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Hannover Re in the live analysis
One click puts Hannover Re on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Broad data
Sep 24, 2026